InsidersTradesSigma
Track the 레메디 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). The latest transaction was reported on 15 July 2026 (Other). Among the most active insiders: 김희철. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
레메디 is a company listed on the XKRX market. It specializes in the health and biotechnology sector.